BACKGROUND/AIMS: In patients with gastroesophageal reflux disease, persistent symptoms on proton pump inhibitor (PPI) therapy may be due to residual acid or non-acid reflux. Combined impedance-pH has been suggested to be superior to pH alone in the management of refractory patients to PPI. The utility of implementation of this technique in every day clinical practice is still unknown. The aim of this study was to investigate the outcomes of patients studied with combined impedance-pH and to evaluate the yield of additional impedance monitoring over pH alone in patients with persistent gastroesophageal reflux disease symptoms. METHODS: Seventy-one patients (31 men; mean age, 49.1 ± 15.5 years) on PPI therapy underwent combined impedance-pH for persistent typical (76%) or atypical (49%) symptoms. RESULTS: During impedance-pH study, 44 (62%) patients reported symptoms. A positive symptom index (SI) was found in 21 (48%) patients: 8 (18.2%) had a positive SI for acid reflux, 9 (20.5%) for non-acid reflux and 4 (9.1%) for mixed reflux. Addition of impedance allowed association between reflux and symptoms in 20.5% of patients who would have been missed by pH study alone. Heartburn was the most prevalent symptom associated with acid reflux, whereas regurgitation and ear, nose and throat symptoms were associated with non-acid reflux. CONCLUSIONS: The use of combined impedance-pH monitoring substantially increased the diagnostic yield compared to pH alone. With SI analysis, 20.5% of patients received a diagnosis that could not have been achieved with pH testing alone.
BACKGROUND/AIMS: In patients with gastroesophageal reflux disease, persistent symptoms on proton pump inhibitor (PPI) therapy may be due to residual acid or non-acid reflux. Combined impedance-pH has been suggested to be superior to pH alone in the management of refractory patients to PPI. The utility of implementation of this technique in every day clinical practice is still unknown. The aim of this study was to investigate the outcomes of patients studied with combined impedance-pH and to evaluate the yield of additional impedance monitoring over pH alone in patients with persistent gastroesophageal reflux disease symptoms. METHODS: Seventy-one patients (31 men; mean age, 49.1 ± 15.5 years) on PPI therapy underwent combined impedance-pH for persistent typical (76%) or atypical (49%) symptoms. RESULTS: During impedance-pH study, 44 (62%) patients reported symptoms. A positive symptom index (SI) was found in 21 (48%) patients: 8 (18.2%) had a positive SI for acid reflux, 9 (20.5%) for non-acid reflux and 4 (9.1%) for mixed reflux. Addition of impedance allowed association between reflux and symptoms in 20.5% of patients who would have been missed by pH study alone. Heartburn was the most prevalent symptom associated with acid reflux, whereas regurgitation and ear, nose and throat symptoms were associated with non-acid reflux. CONCLUSIONS: The use of combined impedance-pH monitoring substantially increased the diagnostic yield compared to pH alone. With SI analysis, 20.5% of patients received a diagnosis that could not have been achieved with pH testing alone.
Entities:
Keywords:
Electric impedance; Esophageal pH monitoring; Gastroesophageal reflux
Authors: S J Sontag; B I Hirschowitz; S Holt; M G Robinson; J Behar; M M Berenson; A McCullough; A F Ippoliti; J E Richter; G Ahtaridis Journal: Gastroenterology Date: 1992-01 Impact factor: 22.682
Authors: Frank Zerbib; Sabine Roman; Alain Ropert; Stanislas Bruley des Varannes; Philippe Pouderoux; Ulriikka Chaput; François Mion; Eric Vérin; Jean-Paul Galmiche; Daniel Sifrim Journal: Am J Gastroenterol Date: 2006-07-18 Impact factor: 10.864
Authors: Daniela Jodorkovsky; Jennifer C Price; Brian Kim; Sameer Dhalla; Ellen M Stein; John O Clarke Journal: Dig Dis Sci Date: 2014-02-23 Impact factor: 3.199
Authors: Anastasios Karlaftis; George Karamanolis; Konstantinos Triantafyllou; Demetrios Polymeros; Asimina Gaglia; Maria Triantafyllou; Ioannis S Papanikolaou; Spiros D Ladas Journal: Ann Gastroenterol Date: 2013
Authors: Lucie Zdrhova; Petr Bitnar; Karel Balihar; Pavel Kolar; Katerina Madle; Milan Martinek; John Erik Pandolfino; Jan Martinek Journal: Dysphagia Date: 2022-07-16 Impact factor: 2.733